Home
Storia in 4 fonti
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar agreements that would make them immune to tariffs.
- ·
scmp.com
Trump says Pfizer will cut drug prices for tariff relief
The White House is also planning a direct-to-consumer website called TrumpRx for Americans to buy medication.
- ·
aljazeera.com
Pfizer strikes deal with Trump administration to cut US drug prices
US consumers not expected to start seeing lower prices under the Pfizer deal until 2026.
- ·
cnbc.com
Trump's pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
Pfizer's deal with Trump was a relief to the pharma industry, signaling that drugmakers could strike similar agreements that would make them immune to tariffs.
- ·
nytimes.com
How TrumpRx Website May Affect Your Drug Costs After Pfizer Deal
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help consumers buy drugs directly from manufacturers.
- ·
Forget Trump’s tariffs — here's what is separating pharma’s winners and losers
Drugmakers rally after Pfizer agreement as Most Favored Nation plans still loom over sector.
- ·
Trump’s 100% tariff threat puts India’s drug industry on edge
While the tariff announcement on patented drugs sent Indian pharma stocks tumbling, a tentative digital trade deal could show a path forward.